-
Expect more questions from patients about hormone therapy (HT) with the publication of three reports from the Womens Health Initiative (WHI), the largest randomized controlled trial conducted to date on the drug therapy.
-
-
The push for chlamydia screening has been intensified, with the Washington, DC-based American College of Preventive Medicine (ACPM) issuing a practice policy statement calling for the annual screening of all sexually active women 25 years of age or younger, as well as sexually active women with other risk factors.
-
When it comes to the battle against HIV, its time to redouble your efforts at reducing the number of new HIV infections. Why? Reports show an increase of newly diagnosed infections during 1999-2001, which reverses a several-year decline.
-
The Food and Drug Administration (FDA) has approved a new device to be used in vasectomy procedures: the Vasclip, a small polymeric clip designed to stop the flow of sperm through the vas deferens.
-
-
Increase in Blood Glucose Concentration During Antihypertensive Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events in Ambulatory Care; Prevention of Hip Fracture by External Hip Protectors
-
Aripiprazole is a new antipsychotic agent approved for the treatment of schizophrenia. This atypical agent is a quinolinone that has partial agonist activity at dopamine D2 receptors. The drug will be marketed as being better tolerated and safer than other atypical agents, as well as being dosed once a day.
-
Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes.
-
An update on Oregons assisted suicide program since it became legal in 1997.